A biotechnology company started out of the University of Wisconsin-Madison has raised $2.3 million almost entirely from investors within the state. Immuto Scientific Inc. plans to use its $2.3 million in seed funding for equipment and staffing needed to take its analytical research services to...
Supporting both innovative and established ways to aid Wisconsin entrepreneurs is key to building a vibrant economy, and a new $2 million grant program is encouraging programs that help emerging businesses thrive....
“I know a lot of people I love would be here today, if their cancers had been detected early.” – Katie Couric...
Imagine the sort of coworking space we’ve all grown used to, but this time it’s for scientists. It’s a place for cash-strapped research teams that have taken the leap and launched small biotech startups with big implications....
Madison cancer diagnostics company Exact Sciences Corp. is working on a test that would screen for multiple types of cancer with a single blood draw. It's aiming to help people catch early-stage cancer so it can be treated quickly. For patients who are willing to...
Expanded collaboration to include an additional 20 targets for multi-specific antibody, antibody-drug conjugate, and other biologic candidate discovery and development...
Research on an experimental flu vaccine by Madison-based FluGen continues to expand, with a low dose showing some protection against a mismatched strain, a higher dose producing better immune responses and three new studies targeting older adults and children, groups among those most at risk...
Pyran, Inc., a high-growth company that creates high-performing 5-carbon products made from renewable resources, today announced that it has closed its latest round of fundraising, bringing its total of investments and grants to nearly $4 million....
Madison-based FluGen has been awarded a $11.4 million grant from the Department of Defense to study the ability of its experimental flu vaccine to protect against drifted flu virus strains in older adults, the company said Thursday....
Nimble Therapeutics and RayzeBio today announced the companies have entered a strategic collaboration to discover and develop novel peptide-based radiopharmaceuticals for treatment of cancer....